Cal-Mag Zinc with Vitamin D3

product on market Tablet or Pill Central Market HEB 🟢 Safety: 100/100
Brand: Central Market HEB
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Tablet(s) Serving Size
50 Servings
Other Combinations Product Type
67% Evidence Coverage

Supplement Facts — Evidence Check

200 IU (50% DV)
✅ Within RDA (0.3× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.005mg UL 0.1mg
Calcium
1000 mg (100% DV)
500 mg (125% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 500mg
25 mg (167% DV)
✅ 2.3× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 25mg UL 40mg
100 mg
📊 Market median: 496.0mg (192 products) 📚 20 studies — no high-quality reviews
This product: 100mg
100 mg
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 100mg

Other Ingredients

Cellulose Calcium Stearate Silica Stearic Acid modified Cellulose Gum Glycerin

Label Claims — Verification

❓ Nutrient
❓ All Other
❓ Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (70% of products) Approved Health (4% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

🧪 Formulation Notes

Promotes bone, nerve, and overall health

Gluten free

Product Details

DSLD Entry Date 2019-12-22
Product Type Other Combinations
Form Tablet or Pill
Brand Central Market HEB
DSLD ID 209853
Data Updated 2026-04-11

Research Evidence

872 Research Sources
53 Avg Quality Score
309 Meta Analysis
309 Clinical Trial
111 Rct
71 Systematic Review
55 Guideline
4 Cochrane Review
4 Regulatory Source
2 Other
2 Narrative Review
2 Observational
1 Openfda Safety
A Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
Meta Analysis The Cochrane database of systematic reviews 2009
PubMed DOI Cochrane
A Vitamin D supplementation for prevention of mortality in adults
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI Cochrane
A Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI Cochrane
A Vitamin D supplementation for prevention of cancer in adults
Meta Analysis The Cochrane database of systematic reviews 2014
PubMed DOI Cochrane
A Interventions for preventing falls in older people in care facilities and hospitals
Meta Analysis The Cochrane database of systematic reviews 2018
PubMed DOI
A Drugs for preventing lung cancer in healthy people
Meta Analysis The Cochrane database of systematic reviews 2020
PubMed DOI
A Vitamin D supplementation for prevention of mortality in adults
Meta Analysis The Cochrane database of systematic reviews 2011
PubMed DOI Cochrane
A High prevalence of vitamin D deficiency in Asia: A systematic review and meta-analysis
Meta Analysis Critical reviews in food science and nutrition 2023
PubMed DOI
A The effect of vitamin D supplementation on depressive symptoms in adults: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2023
PubMed DOI
A Interventions for preventing falls in older people living in the community
Meta Analysis The Cochrane database of systematic reviews 2009
PubMed DOI
View all evidence for Vitamin D →

Compare Similar Products

Vitamin D3 1,000 IU
Vitamin D3 1,000 IU FoodScience Of Vermont 100
Vitamin D-3 1,500 IU Vitabase 100
Vitamin D 400 IU Supplement Nature Made 100
Vitamin D 400 IU Supplement Nature Made 100
Vitamin D 1000 IU Kroger 100
View all Vitamin D products →
Vitamin D research & evidence Best Vitamin D rankings All Vitamin D products More from Central Market HEB View on NIH DSLD →